Lindamood, Christopher A <br/><br/>
Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists.  [electronic resource] 

 -  Clinical therapeutics  Mar 2015 
 - 483-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2015.01.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Clinical Trials, Phase III as Topic<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Exenatide<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Glucagon-Like Peptide-1 Receptor--therapeutic use<br/>Glucagon-Like Peptides--analogs & derivatives<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemia--drug therapy<br/>Hypoglycemic Agents--therapeutic use<br/>Immunoglobulin Fc Fragments--therapeutic use<br/>Liraglutide--therapeutic use<br/>Middle Aged<br/>Peptides--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Receptors, Glucagon--agonists<br/>Recombinant Fusion Proteins--therapeutic use<br/>Venoms--therapeutic use